As of June 14, 2025, Natus Medical Inc (NTUS) reports a Gross Margin of 57.70%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Natus Medical Inc's Gross Margin
Over recent years, Natus Medical Inc's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2021-12-31 | 57.70% |
| 2020-12-31 | 53.62% |
| 2019-12-31 | 58.91% |
| 2018-12-31 | 57.26% |
| 2017-12-31 | 56.13% |
This steady improvement highlights how Natus Medical Inc manages its operational efficiency and pricing power over time.
Comparing Natus Medical Inc's Gross Margin to Peers
To better understand Natus Medical Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Natus Medical Inc (NTUS) | 57.70% |
| Artivion Inc (CRY) | 6625.83% |
| Semler Scientific Inc (SMLR) | 91.55% |
| Zynex Inc (ZYXI) | 79.70% |
| Edwards Lifesciences Corp (EW) | 79.46% |
| AxoGen Inc (AXGN) | 75.79% |
Compared to its competitors, Natus Medical Inc's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.